“…First, LSD more potently bound to 5-HT 2A receptors compared with all of the tryptamines. Second, LSD was absolutely and in most cases also relatively more potent than all of the tryptamines at the 5-HT 1 receptor, which may moderate the in vivo effects of hallucinogens Krebs-Thomson et al, 2006;Sipes and Geyer, 1994;15 Strassman, 1996). Third, all of the novel tryptamines were full agonists at the 5-HT 2A receptor or presented > 50% activation efficacy, whereas LSD, DMT, and psilocin were partial agonists with < 40% activation efficacy.…”